The Chief Scientist Office in Scotland, Action Duchenne and Muscular Dystrophy UK are working in partnership to make possible the award of a clinical academic training fellowship to Dr Shuko Joseph at the University of Glasgow.

Dr Joseph has been awarded the funds for a three-year project, ScOT-DMD to better understand bone deterioration in the 2,500 children and young people living with Duchenne muscular dystrophy in the UK. The £239,000 project is funded equally by the three organisations.

Dr Joseph will use state-of-the-art imaging technologies and biological ‘markers’ to study bone health in people with the condition, and will work with healthcare professionals across Scotland to ensure the best possible protective care.

Alongside laying the foundations for treatments to reduce breaks, Dr Joseph’s appointment will also increase the country’s capacity for clinical trials. With no treatment addressing the underlying cause of Duchenne muscular dystrophy currently widely available in the UK, greater  clinical trial capacity is vital to allow children to benefit from potential therapies, and for new treatments to be developed for Duchenne.